Bank of New York Mellon’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-272,788
| Closed | -$18.6M | – | 4632 |
|
|
2022
Q3 | $18.6M | Buy |
272,788
+18,594
| +7% | +$1.27M | ﹤0.01% | 1541 |
|
|
2022
Q2 | $8.12M | Sell |
254,194
-18,409
| -7% | -$588K | ﹤0.01% | 2061 |
|
|
2022
Q1 | $9.44M | Buy |
272,603
+876
| +0.3% | +$30.3K | ﹤0.01% | 2094 |
|
|
2021
Q4 | $7.95M | Sell |
271,727
-324
| -0.1% | -$9.48K | ﹤0.01% | 2226 |
|
|
2021
Q3 | $6.93M | Buy |
272,051
+6,548
| +2% | +$167K | ﹤0.01% | 2325 |
|
|
2021
Q2 | $9.3M | Buy |
265,503
+42,662
| +19% | +$1.49M | ﹤0.01% | 2178 |
|
|
2021
Q1 | $9.08M | Sell |
222,841
-6,480
| -3% | -$264K | ﹤0.01% | 2138 |
|
|
2020
Q4 | $9.93M | Sell |
229,321
-12,422
| -5% | -$538K | ﹤0.01% | 2005 |
|
|
2020
Q3 | $13.3M | Buy |
241,743
+8,957
| +4% | +$494K | ﹤0.01% | 1701 |
|
|
2020
Q2 | $14.7M | Sell |
232,786
-49,461
| -18% | -$3.12M | ﹤0.01% | 1627 |
|
|
2020
Q1 | $14.4M | Sell |
282,247
-22,070
| -7% | -$1.13M | ﹤0.01% | 1494 |
|
|
2019
Q4 | $24.2M | Sell |
304,317
-230,145
| -43% | -$18.3M | 0.01% | 1455 |
|
|
2019
Q3 | $25.9M | Buy |
534,462
+1,994
| +0.4% | +$96.7K | 0.01% | 1372 |
|
|
2019
Q2 | $28M | Sell |
532,468
-54,104
| -9% | -$2.85M | 0.01% | 1339 |
|
|
2019
Q1 | $31M | Buy |
586,572
+62,501
| +12% | +$3.31M | 0.01% | 1279 |
|
|
2018
Q4 | $21.5M | Buy |
524,071
+288,530
| +122% | +$11.8M | 0.01% | 1429 |
|
|
2018
Q3 | $8.95M | Sell |
235,541
-930
| -0.4% | -$35.3K | ﹤0.01% | 2082 |
|
|
2018
Q2 | $10.7M | Buy |
236,471
+15,211
| +7% | +$688K | ﹤0.01% | 1984 |
|
|
2018
Q1 | $10.7M | Buy |
221,260
+23,059
| +12% | +$1.11M | ﹤0.01% | 1946 |
|
|
2017
Q4 | $7.8M | Buy |
198,201
+9,319
| +5% | +$367K | ﹤0.01% | 2109 |
|
|
2017
Q3 | $5.87M | Buy |
188,882
+4,709
| +3% | +$146K | ﹤0.01% | 2268 |
|
|
2017
Q2 | $5.04M | Buy |
184,173
+44,784
| +32% | +$1.22M | ﹤0.01% | 2331 |
|
|
2017
Q1 | $5.14M | Buy |
139,389
+61,593
| +79% | +$2.27M | ﹤0.01% | 2312 |
|
|
2016
Q4 | $1.12M | Buy |
77,796
+6,521
| +9% | +$94.2K | ﹤0.01% | 3197 |
|
|
2016
Q3 | $1.64M | Buy |
71,275
+28,375
| +66% | +$654K | ﹤0.01% | 2884 |
|
|
2016
Q2 | $712K | Buy |
42,900
+12,940
| +43% | +$215K | ﹤0.01% | 3357 |
|
|
2016
Q1 | $475K | Buy |
29,960
+5
| +0% | +$79 | ﹤0.01% | 3460 |
|
|
2015
Q4 | $969K | Buy |
29,955
+13,770
| +85% | +$445K | ﹤0.01% | 3180 |
|
|
2015
Q3 | $683K | Buy |
+16,185
| New | +$683K | ﹤0.01% | 3386 |
|